-
Hurricane Isaias set to strike Gulf Coast late Friday
-
Rubio calls on all Venezuela opposition figures to join talks with govt
-
Trump forms panel to probe US Fed governor Lisa Cook
-
Australia struggle against South Africa quicks in first Test
-
Clashes in Durban as fresh anti-migrant riots erupt in South Africa
-
Stocks advance as Trump rules out pre-vote Iran attack
-
France students plan more protests, UN 'concerned' over violence
-
Australia struggle against South Africa's fast bowlers
-
De Zerbi calls on struggling Spurs to react in Man Utd clash
-
Massive debt puts France in a bind as investor doubts deepen
-
US sanctions on ICC: a 'test of resilience'
-
Arteta urges 'respect' for process after Man City financial verdict
-
Outrage over US military plan to livestream firing squad execution
-
'Human-authored' book labels gain ground amid AI scandals
-
Argentina snap up defence guru Edwards ahead of World Cup
-
Man City whistleblower Pinto to stay under police protection
-
BMW pulls car lease offer from German far-right politician
-
US leads fresh Ukraine peace push with Miami talks
-
Brazil election offers Jair Bolsonaro a shot at revenge
-
Verstappen continues resurgence with pole for Singapore sprint
-
Man Utd boss Carrick 'personally' affected by Man City verdict
-
Cuban ration book, symbol of the revolution, gathers dust
-
Evolution Metals & Technologies Corp. Raises Fiscal 2026 Revenue Guidance 62% at Midpoint to $10–$11 Million and Reaffirms $400–$460 Million Fiscal 2027 Outlook
-
Stocks advance, oil retreats as Trump rules out pre-vote Iran attack
-
Red Bull's Verstappen takes pole position for Singapore GP sprint race
-
Man City case causing 'uncertainty' for whole Premier League, says Iraola
-
Chelsea star Palmer 'committed' to England insists Alonso
-
Talks with Iran can only succeed without threats, president says
-
OpenAI denies firing researchers over AI safety warnings
-
Home hope Zheng sets up Mertens clash in China Open semis
-
Turkey warns opposition, press over investment fund crisis
-
Lombardia promises gripping end to season in Pogacar absence
-
Hurricane Isaias now major storm as it heads to US Gulf Coast
-
Barca skipper Raphinha out against Getafe and Galatasaray
-
Djokovic crashes out of Shanghai Masters in his first match
-
MEXC and Payward Highlight Collaboration as Crypto and TradFi Converge at TOKEN2049
-
EU says Turkey's crackdown on rights hampers membership bid
-
EU states agree beefed-up European financial markets watchdog
-
Two Renoir paintings stolen in France recovered: mayor
-
Eritrea, Ethiopia trade barbs as Tigray rebels retreat
-
German leader outraged at Schroeder birthday visit to Putin
-
Kompany 'proud' of Man City success despite guilty verdict
-
Stocks up, oil retreats as Trump rules out pre-vote Iran attack
-
Man City will win appeal over financial charges, says Maresca
-
South African judge Navi Pillay wins Nobel Peace Prize
-
Fernandez logs record lap at Indonesia MotoGP practice
-
'I completely trust the club,' says Man City boss Maresca
-
Navi Pillay: S.Africa's global rights activist and Nobel winner
-
'10 out of 10' Quintana reminisces over dream Vuelta win
-
Ufunded Launches “Spotlight” Series, Documenting the Minds Shaping Modern Trading
Most baby formula health claims not backed by science: study
The vast majority of health claims used to advertise baby formula worldwide are not supported by rigorous scientific evidence, a study said Thursday, leading researchers to urge the breast milk substitutes be sold in plain packaging.
The study comes a week after a group of doctors and scientists called for a regulatory crackdown on the $55-billion formula industry for "predatory" marketing which they said exploits the fears of new parents to convince them not to breastfeed.
Breastfeeding is widely recognised to have huge health benefits for babies. The World Health Organization and the US CDC recommend breastfeeding exclusively during the first six months of a newborn's life.
However that recommendation is followed for less than half of infants globally, according to the WHO.
Daniel Munblit, an honorary senior lecturer at Imperial College London and an author of the new study, said researchers were not on a "crusade" against infant formula, which should remain an option for mothers who cannot or choose not to breastfeed.
"But we are very much against inappropriate infant formula marketing, which provides misleading claims not backed up by solid evidence," Munblit told AFP.
Munblit and an international team of researchers looked at the health claims made for 608 products on the websites of infant formula companies in 15 countries, including the United States, India, Britain and Nigeria.
The most common claims were that formula supports brain development, strengthens immune systems and more broadly helps growth.
Half of the products did not link the claimed health benefit to a specific ingredient, according to the study published in the BMJ journal.
Three quarters did not refer to scientific evidence supporting their claims.
Of those that provided a scientific reference, more than half pointed to reviews, opinion pieces or research on animals.
Just 14 percent of the products referred to registered clinical trials on humans. However 90 percent of those trials carried a high risk of bias, including missing data or the finding not supporting the claim, the study said.
And nearly 90 percent of the clinical trials had authors who received funding from or had ties to the formula industry, it added.
- 'Distressing' -
The most commonly cited ingredient was polyunsaturated fatty acids, which is in breast milk and is considered important for brain development.
However there is no evidence of any added benefit when the ingredient is added to baby formula, according to a Cochrane systematic review.
Munblit said the health claims were mostly used to advertise premium formula products, which could be "distressing" for parents who are misled into believing the ingredients are essential but cannot afford them.
When asked what he thinks needs to be done to address the problem, Munblit was concise.
"Plain packaging," he said.
The study comes after a series of papers were published in the Lancet journal last week calling for global policy makers to end exploitative formula marketing.
WHO infant health specialist Nigel Rollins, an author of one of the Lancet papers, said busy parents "lack the time to properly scrutinise claims" about infant formula.
The new study showed that "governments and regulatory authorities must commit the necessary time and attention to review the claims of formula milk products," Rollins said in a linked BMJ editorial.
C.Kovalenko--BTB